Dhr. Havis zal de commercialisering van Europa naar Azië leiden

YOKNEAM, Israël & MIAMI–(BUSINESS WIRE)– Rapid Medical, een toonaangevende ontwikkelaar van neurovasculaire apparaten, kondigt de promotie aan van Eitan Havis tot President, International. De heer Havis zal toezicht houden op de commerciële uitbreiding van de geavanceerde neurovasculaire technologieën van het bedrijf voor de behandeling van patiënten met hemorragische en ischemische beroerte in Europa, Azië en andere geografische gebieden.

Dhr. Havis brengt 20 jaar ervaring als verkoopleider mee voor zowel bedrijven in de groeifase als voor grote bedrijven in medische hulpmiddelen. Hij trad in 2013 in dienst bij Rapid Medical als Vice President Sales en Marketing. Tijdens zijn ambtstermijn hielp hij het bedrijf te laten groeien van een prille start-up tot een goed gefinancierde commerciële operatie. Onder leiding van de heer Havis heeft het bedrijf 3 product franchises gelanceerd, die elk neuro-interventionalisten meer controle geven over de procedurele resultaten dan eerdere aanbiedingen en die in duizenden ziekenhuizen worden gebruikt.

Rapid Medical Announces Eitan Havis as International President

Mr. Havis will Lead Commercialization from Europe to Asia

YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)– Rapid Medical, a leading developer of neurovascular devices, announces the promotion of Eitan Havis to President, International. Mr. Havis will oversee the commercial expansion of the company’s advanced neurovascular technologies to treat hemorrhagic and ischemic stroke patients in Europe, Asia, and other geographies.

Mr. Havis brings 20 years of sales leadership experience for both growth-stage and large medical device companies. He joined Rapid Medical in 2013 as the Vice President of Sales and Marketing. During his tenure, he helped to grow the company from an early-stage start-up to a well-funded commercial operation. With Mr. Havis’s leadership, the company has launched 3 product franchises, each providing neurointerventionalist with greater control over procedural outcomes than previous offerings and gaining adoption in thousands of hospitals.

“Eitan has been a crucial leader in growing the company from its infancy,” commented Ronen Eckhouse, CEO and co-founder of Rapid Medical. “His leadership & professional expertise will enable us to further develop and expand our international presence.”

“Rapid Medical’s devices provide interventionalists with enhanced control inside of the vessel, allowing them to tailor the treatment to each patient,” adds Eitan Havis, President, International, for Rapid Medical. “I am continuously inspired by our talented team as we bring these advanced solutions to physicians across the globe.”

About Rapid Medical

Rapid Medical develops the premier, responsive interventional devices for neurovascular diseases such as ischemic and hemorrhagic stroke. Utilizing novel manufacturing techniques, Rapid Medical’s products are remotely adjustable and fully visible. This enables physicians to respond in real-time to the intravascular environment and have greater control over procedural outcomes. TIGERTRIEVER™17 and 21, COMANECI™ and COLUMBUS™/DRIVEWIRE are CE marked and FDA cleared. TIGERTRIEVER™13 and XL are also CE marked. More information is available at www.rapid-medical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220302005471/en/

Contacts

Ronen Eckhouse

+972-72-2503331

ronen@rapid-medical.com